Table 4 Clinical features, laboratory findings and pituitary volume at 6-month assessment
From: Growth impairment in children with atrophic autoimmune thyroiditis and pituitary hyperplasia
Patients | Height, cm (SDS) | Pubertal Stage (B/G-P) | Clinical findings | TSH, mUI/ml | FT4, pmol/l | TPOAb, IU/ml | TGAb, IU/ml | IGF-1, ng/ml | PRL, uUI/ml | Pituitary volume, mm3 |
|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | 136.7 (-3.5) | B4P2 | Dry and thickened skin | 0.2 | 17.37 | NA | NA | NA | NA | NA |
Patient 2 | 134.4 (-1.81) | B3P3 | No symptoms | 0.239 | 18.7 | 1755 | 291 | 182.2 | 89 | 287.0 |
Patient 4 | 139.1 (-1.5) | G1P1 | No symptoms | 0.4 | 14.9 | 371 | 323.2 | 146 | NA | 327.6 |
Patient 5 | 163.1 (-0.92) | G3P3 | No symptoms | 1.6 | 15.44 | 58.2 | 15.1 | 234.7 | NA | 171.6 |
Patient 6 | 122.1 (-1.69) | B1P1 | No symptoms | 1.12 | 19.3 | 48.1 | 21.8 | 195 | 110.63 | NA |
Patient 7 | 123.5 (-1.46) | B1P1 | No symptoms | 1.8 | 12.99 | 140.4 | 192.4 | 196.1 | 57.44 | NA |
Patient 11 | 163.5 (-0.73) | G5P5 | No symptoms | 1.66 | 15.8 | NA | NA | NA | NA | 563.16 |
Patient 12 | 140.8 (-2.01) | G4P3 | No symptoms | 6.42 | 12.9 | NA | NA | NA | NA | NA |